Memory care breakthrough, or yet another false alarm?
By
John O'Connor
Dec 01, 2022
This week’s Alzheimer’s revelation is a hopeful sign, but even under the best possible scenario, much work remains.
A stumbling block on the way to an Alzheimer’s cure
By
Lois A. Bowers
Nov 14, 2022
In a new study, 56% of participants said they were not likely to take part in a trial of a dementia-prevention drug. Senior living may be able to play a role in decreasing that percentage.
Should residents’ access to Alzheimer’s drug be restricted?
By
Lois A. Bowers
Jan 18, 2022
You have until Feb. 10 to share your comments with CMS about its recent proposal related to Alzheimer’s drug aducanumab (Aduhelm).
Health habits’ connection to dementia in the spotlight as new year begins
By
Lois A. Bowers
Jan 04, 2022
An update to the National Plan to Address Alzheimer’s Disease, as well as news of potential treatments and a finding that “astonished” researchers add up to promising news to start the new...
A very troubling $56 billion question
By
John O'Connor
Jul 08, 2021
Considering some of the alternatives, I’m far from convinced that bankrupting Medicare for the sake of Aduhelm would be money well spent.